Trial Profile

Persistence of antibodies after full vaccination course with GSK Biologicals' Menitorix or MenC conjugate vaccine, co-administered with DTPa or DTPa/Hib containing vaccine and pneumococcal conjugate vaccine, in children up to 6 years of age

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 06 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa) (Primary) ; DTaP vaccine; Meningococcal vaccine group C conjugate; Pneumococcal 10-valent vaccine conjugate; Pneumococcal 7-valent CRM197 vaccine conjugate
Indications Diphtheria; Haemophilus infections; Meningococcal group C infections; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
Focus Pharmacodynamics
Sponsors GlaxoSmithKline; GSK

08 Nov 2013 New source identified and integrated (ClinicalTrials.gov; NCT00891176).
27 Feb 2013 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com